Home › Carcinoma polmonare a piccole cellule › Illinois › Chicago
Studi clinici su Carcinoma polmonare a piccole cellule a Chicago, IL
12 studi su Carcinoma polmonare a piccole cellule cercano partecipanti presso sedi a Chicago e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
In reclutamentoFase 3
- University of Chicago Medical Center /ID# 280149, Chicago
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
In reclutamentoFase 1
- Northwestern University Feinberg School of Medicine, Chicago
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
In reclutamentoFase 1/2
- University of Chicago ( Site 1108), Chicago
Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
In reclutamentoFase 2
- Northwestern, Chicago
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
In reclutamentoFase 3
- Rush MD Anderson Cancer Center, Chicago
Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
In reclutamentoFase 1
- University of Illinois Chicago, Chicago
Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer
In reclutamentoFase 2
- University of Illinois Chicago, Chicago
A Study of LY4175408 in Participants With Advanced Cancer
In reclutamentoFase 1
- The University of Chicago Medical Center (UCMC), Chicago
Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
In reclutamentoFase 2
- University of Illinois Cancer Center, Chicago
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
In reclutamentoFase 2
- Northwestern University, Chicago
Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
In reclutamentoFase 1/2
- Jesse Brown VA Medical Center, Chicago, IL, Chicago
Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)
In reclutamentoFase 2
- University of Chicago Medicine, Chicago
Studi su Carcinoma polmonare a piccole cellule in altre città
- Houston, TX26 studi
- Arlington, VA23 studi
- Boston, MA21 studi
- New York City, NY21 studi
- Nashville, TN20 studi
- Los Angeles, CA20 studi
- Orlando, FL15 studi
- Dallas, TX13 studi
- St. Louis, MO13 studi
- Cleveland, OH13 studi
- Detroit, MI12 studi
- Washington, DC12 studi
Altri studi a Chicago
- Cancro del polmone non a piccole cellule61 studi
- Cancro al seno58 studi
- Cancro (tutti i tipi)51 studi
- Cancro metastatico45 studi
- Cancro alla prostata45 studi
- Obesità41 studi
- Cancro ai polmoni41 studi
- Cancro ovarico36 studi
- Ictus34 studi
- Cancro colorettale33 studi
- Insufficienza cardiaca31 studi
- Sovrappeso28 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.